Thromb Haemost 2024; 124(05): 441-454
DOI: 10.1055/s-0043-1774310
Stroke, Systemic or Venous Thromboembolism

Neutrophil Extracellular Traps: Potential Prothrombotic State Markers and Therapeutic Targets for Atrial Fibrillation

Xing Liu*
1   Department of Cardiology, Tianjin key laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China
,
Xinjian Li*
1   Department of Cardiology, Tianjin key laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China
,
Shenglin Xiong
2   Department of Cardiology, You Country People's Hospital, Zhuzhou, Hunan, China
,
Haipeng Zhang
3   Department of Clinical Laboratory, The Second Hospital of Tianjin Medical University, Tianjin, China
,
Rong Suo
4   Department of Cardiology, Tianjin Hospital, Tianjin, China
,
Xu Zhang
1   Department of Cardiology, Tianjin key laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China
,
Daiqi Liu
1   Department of Cardiology, Tianjin key laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China
,
Huaying Fu
1   Department of Cardiology, Tianjin key laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China
,
Tong Liu
1   Department of Cardiology, Tianjin key laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China
,
1   Department of Cardiology, Tianjin key laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China
› Institutsangaben

Funding This work was supported by grants from the National Natural Science Foundation of China (grant number 81900314), the Scientific Research Fund Project of Key Laboratory of Second Hospital of Tianjin Medical University (grant number 2019ZDSYS16), and Tianjin Key Medical Discipline (Specialty) Construction Project (grant number TJYXZDXK-029A).


Preview

Abstract

Background Recently, the mechanism of thrombogenesis has taken a new direction with the involvement of neutrophil extracellular traps (NETs). However, little is known about the relationship between NETs and thrombogenesis in atrial fibrillation (AF).

Objective Our study aimed to evaluate NETs in AF patients and their potential association with thrombogenesis. In addition, we studied the effect of NETs on thrombogenesis in rat models.

Methods A total of 125 AF patients and 172 controls were studied. Spontaneous echo contrast (SEC) was examined using transesophageal echocardiography to assess the prothrombotic state. We used rapid atrial pacing (RAP) rat models to study NETs' formation and their effects on thrombogenesis. The levels of NETs were analyzed by flow cytometry. To deeply understand the regulatory mechanism of NET formation, the transcriptional characteristics of the left atrial appendage (LAA) tissue from RAP rats were analyzed.

Results We found that NETs were increased significantly in AF patients and positively correlated with SEC grades. And inserting the NET level could significantly enhance the predictivity of CHA2DS2-VASc scores for the AF prothrombotic state. In the RAP models, we observed that NET levels increased significantly in the LAA and promoted thrombosis. Meanwhile, we found that these changes could be suppressed by the NET formation inhibitor. Transcriptomic analysis of the LAA tissue from RAP rats suggested that RAP might stimulate the NET formation by promoting the expression of inflammatory cytokine and adhesion genes.

Conclusion NETs may constitute useful thrombogenesis risk markers in AF patients and provide a potential therapeutic strategy for AF management.

Ethics Approval Statement

The study was carried out following the Declaration of Helsinki and approved by The Second Hospital of Tianjin Medical University Ethics Committee (KY2021K124).


Data Availability Statement

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.


* These authors contributed equally to this article.


Supplementary Material



Publikationsverlauf

Eingereicht: 29. Mai 2023

Angenommen: 02. August 2023

Artikel online veröffentlicht:
21. September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany